NDC 62856-405 – Dayvigo

Lemborexant 5 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug DEA schedule CIV

Product NDC62856-405

Product details

Brand name
Dayvigo
Generic name
lemborexant
Labeler
Eisai Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA212028
Marketed since
April 7, 2020
Listing expires
December 31, 2026
Pharmacologic class
Orexin Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Dayvigo →

Package NDC codes (3)

Package NDCDescriptionSince
62856-405-10 sample1 BLISTER PACK in 1 CARTON (62856-405-10) / 10 TABLET, FILM COATED in 1 BLISTER PACKApr 7, 2020
62856-405-3030 TABLET, FILM COATED in 1 BOTTLE (62856-405-30)Apr 7, 2020
62856-405-9090 TABLET, FILM COATED in 1 BOTTLE (62856-405-90)Apr 7, 2020

Other Dayvigo products